drugset / Press release
Emergent BioSolutions Presents Preclinical Data on ES414, Its Lead Bispecific ADAPTIR Therapeutic for Prostate Cancer
2013-11-06 · Emergent BioSolutions · original emergentbiosolutions.com ↗
110613 - ES414 at PEGS Europe FINAL.pdf 212.3 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗